Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BioSource International, Inc. Presenting at the UBS Warburg Life Science Conference.


Business Editors & Health/Medical Writers

CAMARILLO, Calif.--(BUSINESS WIRE)--Sept. 17, 2002

BioSource International, Inc. (Nasdaq:BIOI), a leading supplier of biological reagents to the life science market, today announced that Len Hendrickson, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  and Charles Best, CFO See Chief Financial Officer.  will present at the UBS UBS Union Bank of Switzerland
UBS United Bible Societies
UBS United Blood Services
UBS United Buying Service
UBS Used Bookstore
UBS University Business Services
UBS Universal Building Society (UK)
UBS Ulaanbaatar Broadcasting System
 Warburg Global Life Sciences Conference held at The Plaza Hotel in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
 on October 10, 2002. The conference runs from October 7 - 10, 2002, during which over 400 companies will present to an expected audience of over 3,000 attendees.

BioSource International, Inc. is a broad based life sciences company focused on providing integrated solutions in the areas of functional genomics, proteomics, and drug discovery through the development, manufacturing, marketing and distribution of unique biologically active reagent systems which facilitate, enable and accelerate pharmaceutical development and biomedical research.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Sep 17, 2002
Words:133
Previous Article:Euronet Anticipates a Reduction in Operating Profit for Q3 and Announces the Signature of a Large Outsourcing Contract.
Next Article:S&P Affirms BCBS of Nebraska and Sub 'A+' Ratings.
Topics:



Related Articles
Cytyc CEO to Present At UBS Warburg Global Life Sciences Conference.
Varian Medical Systems, Inc. Management to Present At UBS Warburg Global Life Sciences Conference.
Novoste to Participate in the UBS Warburg Global Life Sciences Conference.
SangStat to Present At UBS Warburg Global Specialty Pharmaceuticals Conference.
Zoll Medical Corporation to Speak At UBS Warburg Global Life Sciences Conference.
Ventana to Present at UBS Warburg Global Life Sciences Conference.
BioSource International, Inc. to Announce First Quarter 2003 Financial Results on April 29, 2003.
BioSource International, Inc. to Announce Second Quarter 2003 Financial Results on July 22, 2003.
BioSource Board Unanimously Rejects Bio-Rad Offer.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles